首页|指南临床适用性评价指标体系的系统评价

指南临床适用性评价指标体系的系统评价

扫码查看
目的 系统评价全球指南临床适用性评价指标体系,为循证建立适用于我国诊疗环境的指南临床适用性评价指标体系提供依据.方法 计算机检索PubMed、Embase、Cochrane Library、CNKI、WanFang Data和VIP数据库,搜集有关指南临床适用性评价指标体系的文献,检索时限均为建库至2022年11月.由2名研究员独立筛选文献、提取数据后,通过定性系统评价及主题分析法整理资料,形成评价条目池.结果 共纳入82篇文献,获得指南临床适用性评价指标141个,其中第三级主题5个、分析性主题14个、描述性主题141个.第三级主题包括可获得性、可读性、可行性、可接受性和总体评价.可行性领域的影响因素包括医务人员因素、患者/患者家属因素、环境因素和指南因素.结论 本研究系统性地梳理了指南临床适用性评价条目,为构建我国相关评价指标体系提供了循证参考.
Clinical applicability of guidelines evaluation index system:a systematic review
Objective To systematically review the clinical applicability of the global guidelines evaluation index system,and to provide some foundation for the evidence-based establishment of the clinical applicability evaluation index system in China.Methods The PubMed,Embase,Cochrane Library,CNKI,WanFang and VIP databases were electronically searched to collect literature on the clinical applicability evaluation index system of guidelines from inception to November 2022.Two reviewers independently screened literature,extracted data and then organized the data to form the evaluation items pool through qualitative systematic review and thematic synthesis.Results A total of 82 articles were finally included,and 141 clinical applicability evaluation indicators were obtained,including 5 third-level topics,14 analytical topics and 141 descriptive topics.The third-level topics were availability,readability,feasibility,acceptability and overall evaluation.Influencing factors in the feasibility field were summarized as medical staff factors,patient/patient family factors,environmental factors and guideline factors.Conclusion This study systematically sort out the applicability evaluation items of the guidelines,which provide an evidence-based reference for the construction of relevant evaluation index systems in China.

GuidelineClinical applicabilityEvaluation itemsSystematic review

石雨晴、刁莎、曾力楠、易秋莎、李海龙、杨稀策、何苗、郭家平、黄超、王强、张伶俐

展开 >

四川大学华西药学院(成都 610041)

四川大学华西第二医院药学部(成都 610041)

四川大学华西第二医院循证药学中心(成都 610041)

国家药品监督管理局药物制剂体内外相关性技术研究重点实验室(成都 610041)

出生缺陷与相关妇儿疾病教育部重点实验室(成都 610041)

四川大学华西医院(成都 610041)

黄石市中心医院(湖北理工学院附属医院)(湖北黄石 435000)

赣南医学院第一附属医院(江西赣州 341000)

国家卫生健康委医疗管理服务指导中心(北京 100044)

四川大学华西医院中国循证医学中心(成都 610041)

展开 >

指南 临床适用性 评价条目 系统评价

国家卫健委医管中心委托项目

医管中心标准管理处[2020]054号

2024

中国循证医学杂志
四川大学

中国循证医学杂志

CSTPCD北大核心
影响因子:1.761
ISSN:1672-2531
年,卷(期):2024.24(1)
  • 3